Tempest Therapeutics Inc. sell Lokrim
Start price
23.08.21
/
20%
€12.22
Target price
23.08.22
-
Performance (%)
-78.40%
End price
24.08.22
€2.64
Summary
This prediction ended on 24.08.22 with a price of €2.64. Lokrim correctly predicted massive losses of -78.40% for Tempest Therapeutics Inc.. Lokrim has 20% into this prediction This prediction was marked as speculative and is excluded from Lokrim's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Tempest Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to Lokrim what are the pros and cons of Tempest Therapeutics Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Growths slower than the competition
Little known brand
Comments by Lokrim for this prediction
In the thread Tempest Therapeutics Inc. diskutieren
Sell Tempest Therapeutics Inc.
In the thread Trading Tempest Therapeutics Inc.
Die von Lokrim gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Lokrim for Tempest Therapeutics Inc.
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.40
04.08.24
04.08.24
-
04.08.25
04.08.25
-67.39%
05.08.25
05.08.25
Risky Investment
Growths slower than the competition
Little known brand
